Business Daily Media

Business Marketing

.

Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial

  • Written by PR Newswire

SYDNEY, July 28, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has commenced its 64/67Cu SAR-bisPSMA theranostic clinical trial in patients with metastatic castrate resistant prostate cancer (mCRPC) in the US. Patient...

Popular

How To Make Flyers On Your Smartphone

Being in a fast-paced society where you need to maximize your time doing your tasks, we constantly search for ways to make things easier for us. We often rely on technology for our day to day tasks. Smartphones, for instance, is n...

Jake Dyson reveals the next stage of Dyson’s £2.75bn five-year investment plan

Dyson engineers are working on a new generation of intelligent, self-improving, connected products, as the company builds up its software-based team, Jake Dyson, Chief Engineer, reveals in a new Dyson YouTube video. He says th...

Customer expectations are evolving - here's how to meet and exceed their demands

Four years is a long time in retail. Since March 2020, Australian retailers have contended with a pandemic, the closure of highstreets, an eCommerce boom and medium- to long-term economic pressures. Resilience, adaptation and ev...